Skip to main content
Signal8

ASP Isotopes Inc. (ASPI)

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters in Boca Raton, Florida.

Sector: Miscellaneous Chemical Products

Industry: Chemicals - Specialty

ASP Isotopes Inc. Common Stock logo

ASP Isotopes Inc. Common Stock

NASDAQ:ASPIBasic Materials
-10.06%$1.39
Mkt Cap$215.83M
EV-
Float122.67M
O/S155.83M
VOL3.16M sh
$ Vol$4.5M
RVOL0.82×
Inst Own40.5%
Net Cash/Sh-
Dilution
ASP Isotopes Inc. Common Stock logoNASDAQ:ASPI$1.39-10.06%

ASP Isotopes Inc. (ASPI) dilution facts from SEC filings

Snapshot as of Sep 30, 2026, built from 52 SEC filings.

Shelf registration
S-3ASR filed Jul 16, 2026, effective Jul 16, 2026
Source: S-3ASR filed Jul 16, 2026
At-the-market (ATM) program
No active program in the filings reviewed
Warrants outstanding
1 warrant series recorded as outstanding
Most recent offering
Public offering, priced Oct 15, 2025
Source: 10-Q filed Nov 16, 2026

Check another stock for dilution

Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.

Unlock with Signal8 Pro